Recent advances in the development of peptide-based inhibitors targeting epigenetic readers of histone lysine acetylation and methylation marks
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in the development of peptide-based inhibitors targeting epigenetic readers of histone lysine acetylation and methylation marks
Authors
Keywords
-
Journal
CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 75, Issue -, Pages 102334
Publisher
Elsevier BV
Online
2023-05-30
DOI
10.1016/j.cbpa.2023.102334
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BET bromodomain inhibitors
- (2022) Martin P. Schwalm et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs
- (2022) Yuan Zhao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections
- (2022) Ram K. Modukuri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia
- (2022) Yiman Liu et al. Cancer Discovery
- A Potent, Selective CBX2 Chromodomain Ligand and its Cellular Activity during Prostate Cancer Neuroendocrine Differentiation
- (2021) Sijie Wang et al. CHEMBIOCHEM
- Discovery of an H3K36me3-Derived Peptidomimetic Ligand with Enhanced Affinity for Plant Homeodomain Finger Protein 1 (PHF1)
- (2021) Isabelle A. Engelberg et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions
- (2021) Xuefei Wang et al. Frontiers in Chemistry
- A Peptidomimetic Ligand Targeting the Chromodomain of MPP8 Reveals HRP2’s Association with the HUSH Complex
- (2021) Jarod M. Waybright et al. ACS Chemical Biology
- Concise solid-phase synthesis enables derivatisation of YEATS domain cyclopeptide inhibitors for improved cellular uptake
- (2021) Yixiang Jiang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Improved methods for targeting epigenetic reader domains of acetylated and methylated lysine
- (2021) Isabelle A. Engelberg et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Discovery of Potent Peptidomimetic Antagonists for Heterochromatin Protein 1 Family Proteins
- (2021) Kelsey N. Lamb et al. ACS Omega
- Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
- (2020) Emily J. Faivre et al. NATURE
- Selective targeting of BD1 and BD2 of the BET proteins in cancer and immuno-inflammation
- (2020) Omer Gilan et al. SCIENCE
- Targeting epigenetic reader domains by chemical biology
- (2020) Alessandra Cipriano et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Domain-selective targeting of BET proteins in cancer and immunological diseases
- (2020) Massimo Petretich et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Cyclic peptides can engage a single binding pocket through highly divergent modes
- (2020) Karishma Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Targeting of AF9 YEATS Domain by Cyclopeptide Inhibitors with Preorganized Conformation
- (2020) Yixiang Jiang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A General TR-FRET Assay Platform for High-Throughput Screening and Characterizing Inhibitors of Methyl-Lysine Reader Proteins
- (2019) Justin M. Rectenwald et al. SLAS Discovery
- Bromodomains: a new target class for drug development
- (2019) Andrea G. Cochran et al. NATURE REVIEWS DRUG DISCOVERY
- Selection of DNA-Encoded Libraries to Protein Targets within and on Living Cells
- (2019) Bo Cai et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Bromodomain biology and drug discovery
- (2019) Nilesh Zaware et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor
- (2019) Sijie Wang et al. ACS Chemical Biology
- Chemical and Biochemical Perspectives of Protein Lysine Methylation
- (2018) Minkui Luo CHEMICAL REVIEWS
- Interfering peptides targeting protein–protein interactions: the next generation of drugs?
- (2018) Heriberto Bruzzoni-Giovanelli et al. DRUG DISCOVERY TODAY
- Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer
- (2018) Chih-Chao Hsu et al. GENES & DEVELOPMENT
- Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain
- (2018) Robert P. Law et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-guided development of YEATS domain inhibitors by targeting π-π-π stacking
- (2018) Xin Li et al. Nature Chemical Biology
- Transcription control by the ENL YEATS domain in acute leukaemia
- (2017) Michael A. Erb et al. NATURE
- ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia
- (2017) Liling Wan et al. NATURE
- YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer
- (2017) Wenyi Mi et al. Nature Communications
- Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2
- (2017) Kimberly D. Barnash et al. ACS Combinatorial Science
- Chromodomain Ligand Optimization via Target-Class Directed Combinatorial Repurposing
- (2016) Kimberly D. Barnash et al. ACS Chemical Biology
- Peptide-based inhibitors of protein–protein interactions
- (2016) Paulina Wójcik et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1
- (2016) Jacob I Stuckey et al. Nature Chemical Biology
- Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression
- (2014) Mar Gacias et al. CHEMISTRY & BIOLOGY
- Chromodomain Antagonists That Target the Polycomb-Group Methyllysine Reader Protein Chromobox Homolog 7 (CBX7)
- (2014) Chakravarthi Simhadri et al. JOURNAL OF MEDICINAL CHEMISTRY
- Readout of Epigenetic Modifications
- (2013) Dinshaw J. Patel et al. Annual Review of Biochemistry
- Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
- (2013) Olivier Mirguet et al. JOURNAL OF MEDICINAL CHEMISTRY
- RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
- (2013) S. Picaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Perceiving the epigenetic landscape through histone readers
- (2012) Catherine A Musselman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Signals and Combinatorial Functions of Histone Modifications
- (2011) Tamaki Suganuma et al. Annual Review of Biochemistry
- Readers of histone modifications
- (2011) Miyong Yun et al. CELL RESEARCH
- Epigenetic virtues of chromodomains
- (2011) Bartlomiej J. Blus et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Druggability of methyl-lysine binding sites
- (2011) C. Santiago et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Recognition and Specificity Determinants of the Human Cbx Chromodomains
- (2010) Lilia Kaustov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started